Yongfeng Yu

机构：Shanghai Chest Hospital

发表论文 89 篇 · 总被引 1299 次 · h-index 19

代表论文

• Gumarontinib in patients with non-small-cell lung cancer harbouring MET exon 14 skipping mutations: a multicentre, single-arm, open-label, phase 1b/2 trial (2023 · EClinicalMedicine · 被引 54)
• Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer (2024 · Thoracic Cancer · 被引 19)
• Comprehensive molecular characterizations of stage I–III lung adenocarcinoma with tumor spread through air spaces (2023 · Frontiers in Genetics · 被引 16)
• Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC (2023 · Therapeutic Advances in Medical Oncology · 被引 16)
• FGFR1 promotes tumor immune evasion via YAP-mediated PD-L1 expression upregulation in lung squamous cell carcinoma (2022 · Cellular Immunology · 被引 16)
• EGFR-mutant NSCLC may remodel TME from non-inflamed to inflamed through acquiring resistance to EGFR-TKI treatment (2024 · Lung Cancer · 被引 14)